期刊文献+

病毒IL-10的研究进展 被引量:1

Advancement in viral interleukin-lO
原文传递
导出
摘要 病毒IL-10(vlL-10)是EB病毒基因组中一段开放读码区BCRFl编码的蛋白质,约85%的氨基酸与IL-10相同,具有抗炎及免疫抑制等作用。vlL-10主要是通过下调或抑制免疫反应扩大的细胞因子来改善移植物的存活,有研究者将vlL-10转移到气管、心脏、角膜等器官,对其进行了抗炎、抗排斥等方面的研究,为vlL-10的临床应用提供了有力的实验依据。 Viral interleukin-10(vIL-10) is a protein encoded by EB virus in its open reading frame BCRF1. About 85% of its amino acids are the same as IL-10. vIL-10 also has anti-in- flammatory and immunosuppressive effects, vIL-10 improves the survival of transplanted or-gans primarily through the reduction or suppression of cytokines the immune response . Researches have been done on vIL-10 about its performance in anti-inflammatory and anti-rejection through transferring vIL-10 to trachea, heart, corneas and other organs. These studies provided a strong experimental basis.for the clinical application of vIL-10.
出处 《国际免疫学杂志》 CAS 2008年第3期226-229,共4页 International Journal of Immunology
基金 基金项目:山东省中青年科学家科研奖励基金资助项目(2007BS03031)
关键词 病毒白介素-10 免疫抑制 移植 Viral interleukin-10 Immune suppression Transplantation
  • 相关文献

参考文献7

二级参考文献49

  • 1代成波,刘丽萍.2005年卒中炎症和免疫反应在血管性疾病中的利与弊研究进展[J].中国卒中杂志,2006,1(4):303-304. 被引量:32
  • 2Kevin WM, de Waal Malefxt R, Roert L, et al. Interleukin -10 and interleukin-10 receptor. Ann Rev Immunol,2001,19:683-785.
  • 3Wynler EA, Coutinho LH, Marsh JC, et al. Comparision of purity and enrichment of CD+34 cell of bone marrow, umbilical cord and peripheral blood (primed of apheresis)using five separation systems. Stem Cell, 1995,13:524-532.
  • 4Yamada A, Chandraker A, Laufer TM, et al. Recipient MHC class II expression is required to achieve long-term survival of murine cardiac allografts after costimulatory blockade. J Immunol, 2001,167:5522-5526.
  • 5Billingham ME, Path FRC, Cary NRB , et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection :heart rejection study group . J Heart Transplant, 1990,9:587-593.
  • 6David A, Chetritt J,Guillot C, et al. Interleukin-10 produced by recombinant adenovirus prolongs survival of cardiac allografts in rats. Gene Ther, 2000, 7:505-510.
  • 7Li W, Lu L, Li Y, et al. High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporin and tacrolimus in mouse cardiac transplantation. Transplant Proc, 1997,29:1081-1082.
  • 8Qin L, Keuneth DC, Ding Y, et al. Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J Immunol , 1996,156:2316-2323.
  • 9Rasanen-Sokolowski A, Glysing-Jensen T, Russell ME . Leukocyte -suppressing influences of interleukin(IL)-10 in cardiac allografts: insights from IL-10 knockout mice. Am J Pathol, 1998,153: 1491-1500.
  • 10de Waal Malefyt, Haanen J, Spits H, et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med, 1991,174:915-924.

共引文献8

同被引文献11

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部